Uncategorized

The Effect of Maternal Obesity on Maternal and Neonatal outcome in Pregnant Saudi Females

Posted on Updated on

Obese women are at an increased risk of various adverse pregnancy outcomes. The aim of our study was to evaluate the impact of obesity on maternal and neonatal outcomes in Saudi Pregnant Females and to compare obstetric outcomes by the level of maternal obesity.

Visit: https://www.scitechnol.com/womens-health-issues-care.php

Advertisements

Estimation of IgE levels and basophile count in type I hypersensitivity

Posted on Updated on

Three ml of venous blood samples from 20 patients with confirmed type I hypersensitivity, 13 patients were females and 7 males in addition to 20 healthy control samples were enrolled in this study, all samples were subjected for (ELISA test) (Enzyme Linked Immunosorbent assay) to estimate the IgE Levels, in addition to a drop of capillary blood by finger puncture for preparation of blood film for blood basophile count. Cases included systemic anaphylaxis and localized hypersensitivity reaction such as hay fever, asthma, food allergies and eczema. Case sheet was organized for each case.

Visit : https://www.scitechnol.com/journal-clinical-immunology-research.php

Juvenile Myelomonocytic Leukemia

Posted on Updated on

Juvenile Myelomonocytic Leukemia (JMML) is a rare childhood cancer that usually occurs in children younger than 2 years old. There are three main types of mutations found in Juvenile myelomonocytic leukemia which occur in a type of white cell known as a monocyte, which are a part of the body’s immune system, Juvenile myelomonocytic leukemia is a serious form of chronic leukaemia. Juvenile myelomonocytic leukemia accounts for less than 1% of all childhood leukaemias diagnosed. Cause of Juvenile myelomonocytic leukemia remains largely unknown. Allogeneic (donor) Stem Cell transplant is the only curative option for children with Juvenile myelomonocytic leukemia.

Read more at https://www.scitechnol.com/journal-of-blood-research-and-hematologic-diseases.php

JML

Polycythemia vera

Posted on Updated on

Polycythemia vera is a unique blood disorder in which there is an raise in all blood cells, particularly red blood cells. The increase in blood cells makes your blood thicker. This can lead to strokes or tissue and organ damage. Polycythemia vera is caused by a genetic change that develops during your lifetime. It is not an inherited genetic disorder. In most cases it is not known why this happens. There is no cure for polycythemia vera, but proper treatment can help to reduce or delay any problems. Work with your healthcare provider to create a treatment plan that fits your needs. You should also be physically active in order to increase your heart rate and improve your blood flow and also avoid situations in which you could be hurt, and check your feet for any sores.

ALT TAG
ALT TAG

Arterial Embolism

Posted on Updated on

Arterial Embolism is the abrupt intrusion of blood flow, due to a blood clot complies with the wall of an artery. This can shorten vital blood flow in tissues and organs effectually all over in the body. Though, blood clots in the arterial circulatory system lead to disturb the arms, legs, or feet in the bulk cases. Areas in which arterial emboli aim to lodge and delay blood flow are arterial bifurcations and areas diminish by atherosclerosis.

Read more at https://bit.ly/2IJtM75

Thromboembolus

Paroxysmal Cold Hemoglobinuria

Posted on Updated on

Paroxysmal cold hemoglobinuria is a unique form of cold antibody hemolytic anemia. Ruin of red blood cells results from display to cold. Red blood cells perhaps ruin even when cold exposure is finite to a small area of the body. An antibody binds to red blood cells at low temperatures and aim destruction of red blood cells within arteries and veins later warming. It arises repeatedly after a viral illness or in contrarily healthy people, despite it occurs in a few people with syphilis.

Read more at https://bit.ly/2IJtM75

 

Auto immune

Lights and Shadows of Distal Deep Vein Thrombosis

Posted on Updated on

Distal deep venous thrombosis (DDVTs) is one of the grey areas of venous thromboembolism. There is a great heterogeneity in the diagnostic and therapeutic strategies between all the diagnostic centres. Studies doesn’t clarify the problem so it is not clear yet if there is any advantage in diagnosing and consequentially treating all the IDDVT. The 2012 ACCP guidelines suggested clinical observation for 2 weeks over initial anticoagulation (grade 2C) in patients with acute IDDVT without severe symptoms or risk factors for extension.

Read more at https://bit.ly/2IJtM75

Submit manuscript at editor.jbrhd@scitechnol.com

Deep vein thrombosis.jpg